In this week’s Medical Discovery News by UTMB’s David Niesel and Norbert Herzog: Your tongue isn’t the only part your body that can taste sweetness. Three years ago, scientists discovered that our intestines and pancreas have receptors that can sense the sugars, glucose and fructose. This could revolutionize treatment for diabetics, who must closely monitor their blood sugar levels. A drug called New-Met, made by Eleclyx Therapeutics in San Diego - that is now in phase II clinical trials - is attempting to do just that by targeting those sugar receptors in the digestive system.